Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- carbamazepine
- valproic acid
Interactions between your drugs
carBAMazepine valproic acid
Applies to: carbamazepine, valproic acid
MONITOR: Carbamazepine usually decreases valproate levels, and valproate may alter carbamazepine levels in unpredictable ways. Additionally, valproate may prolong the elimination half-life of carbamazepine epoxide. Multiple complex mechanisms may be involved.
MANAGEMENT: Patients who must take both drugs should be carefully monitored for clinical and laboratory evidence of altered effects, particularly when the dosage of either drug is changed.
References (11)
- Levy RH, Moreland TA, Morselli PH, et al. (1984) "Carbamazepine/valproic acid interaction in man and rhesus monkey." Epilepsia, 25, p. 338-45
- Jann MW, Fidone GS, Israel MK, Bonadero P (1988) "Increased valproate serum concentrations upon carbamazepine cessation." Epilepsia, 29, p. 578-81
- Sackellares JC, Sato S, Dreifuss FE, Penry JK (1981) "Reduction of steady-state valproate levels by other antiepileptic drugs." Epilepsia, 22, p. 437-41
- Pisani F, Caputo M, Fazio A, et al. (1990) "Interaction of carbamazepine, with valproate: a pharmacokinetic study." Epilepsia, 31, p. 339-42
- Kondo T, Otani K, Hirano T, et al. (1990) "The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid." Br J Clin Pharmacol, 29, p. 116-9
- Ahuja YR (1981) "Chromosone-damaging action of isoniazid and thiacetazone on human lymphocyte cultures in vivo." Hum Genet, 57, p. 321-2
- Koup JR, Toothaker RD, Posvar E, et al. (1990) "Theophylline dosage adjustment during enoxacin coadministration." Antimicrob Agents Chemother, 34, p. 803-7
- Henriksen O, Johannessen SI (1982) "Clinical and pharmacokinetic observations on sodium valproate: a 5-year follow-up study in 100 children with epilepsy." Acta Neurol Scand, 65, p. 504-23
- Adams DJ, Luders H, Pippenger C (1978) "Sodium valproate in the treatment of intractable seizure disorders: a clinical and electroencephalographic study." Neurology, 28, p. 152-7
- Tohen M, Castillo J, Pope HG, Herbstein J (1994) "Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders." J Clin Psychopharmacol, 14, p. 67-70
- Riva R, Albani F, Contin M, Baruzzi A (1996) "Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations." Clin Pharmacokinet, 31, p. 470-93
Drug and food interactions
carBAMazepine food
Applies to: carbamazepine
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of carbamazepine. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
In a small, randomized, crossover study, the administration of carbamazepine with grapefruit juice (compared to water) increased plasma drug concentrations by approximately 40%. The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.
MANAGEMENT: Patients receiving carbamazepine should be advised to avoid or limit consumption of alcohol. Given the drug's narrow therapeutic index, patients receiving carbamazepine therapy should preferably avoid the regular consumption of grapefruits and grapefruit juice to prevent any undue fluctuations in plasma drug levels. Patients should be advised to report signs of carbamazepine toxicity (nausea, visual disturbances, dizziness, or ataxia) to their physicians.
References (3)
- (2002) "Product Information. Tegretol (carbamazepine)." Novartis Pharmaceuticals
- Garg SK, Kumar N, Bhargava VK, Prabhakar SK (1998) "Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy." Clin Pharmacol Ther, 64, p. 286-8
- Bailey DG, Dresser GR, Kreeft JH, Munoz C, Freeman DJ, Bend JR (2000) "Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients." Clin Pharmacol Ther, 68, p. 468-77
valproic acid food
Applies to: valproic acid
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
References (4)
- Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
- Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
- (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
- (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Vraylar
Vraylar is a once a day antipsychotic medication used to treat mental health or mood disorders ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Abilify
Abilify is an antipsychotic medicine used to treat the symptoms of schizophrenia and bipolar ...
Seroquel
Seroquel is used to treat the symptoms of schizophrenia, bipolar disorder and major depressive ...
Prozac
Prozac (fluoxetine) is an SSRI antidepressant used to treat depression, OCD, panic disorder ...
Lamictal
Lamictal is an anti-epileptic medication used treat seizures in adults and children over 2 years ...
Lyrica
Lyrica is used to control seizures, treat nerve pain and fibromyalgia. Learn about side effects ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.